Navigation Links
NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting
Date:10/13/2008

MAUI, Hawaii, Oct. 13 /PRNewswire/ -- NeoVista, Inc., presented yesterday the anatomic effects of the company's novel epiretinal brachytherapy device on choroidal neovascular lesions in an analysis at the American Society of Retina Specialist's (ASRS) 26th Annual Meeting. The 12-month data presented by David Brown, MD, F.A.C.S., of The Methodist Hospital, Houston, Texas, demonstrated anatomic improvements on both angiography and ocular coherence tomography (OCT) in many patients treated in the ongoing pilot study. NeoVista's therapy, when delivered concomitantly with an intravitreal anti-vascular endothelial growth factor (anti-VEGF) agent, demonstrated a marked reduction in choroidal neovascular membrane (CNVM) size in many patients in the trial, which has not been seen in previous anti-VEGF monotherapy trials.

The current standard of care for wet AMD involves repeated monthly intravitreal injections of an anti-VEGF agent for an indefinite period of time. In contrast, NeoVista's therapy applies a targeted dose of beta radiation to the leaking blood vessels that affect central vision; concomitantly, two injections of an anti-VEGF agent are delivered one month apart to maximize the acute therapeutic response and additional anti-VEGF injections are given on a PRN basis.

"After reviewing the anatomical data outcomes from the Phase II pilot study, I believe this concomitant approach to treating wet AMD looks promising as a potential way to decrease the number of required injections necessary in the treatment of patients with neovascular AMD," said Dr. Brown. "At 12 months, many patients were fluid free on OCT with reductions in FFA lesion size despite being undertreated with the PRN anti-VEGF agents. As this biologic response seems to be observed at six to nine months after the epiretinal brachytherapy procedure, my personal opinion is that the use of more anti-VEGF therapy immediately post treatment may improve the excellent visual acuity results w
'/>"/>

SOURCE NeoVista, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer
2. The Lewin Group Presents McCain and Obama Health Policies: Cost and Coverage Compared Analysis
3. Stater Bros. Markets Presents $1,143,000 Check to Muscular Dystrophy Association
4. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
5. AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska
6. USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution
7. AMA Foundation Presents $10,000 Scholarships to Promising Medical Students
8. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
9. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
10. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
11. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...N, Nov. 9 Today,s drama...gs us one step closer to meaningful health care re...th Care for America Act makes health care more acc...y enhancing coverage, promoting preventive care an...lso serves as a sober reminder of the tremendous a...
(Date:11/9/2009)... New Health Care Reform Bill, The Afford...he House Of Representatives Saturday Night, and Is...bama by the End of the Year with Absolute Confiden...alist Certification Class Specifically for the Com...% of Americans , Hanover ...
(Date:11/9/2009)... Only 5 percent of seniors have changed ...avings, better service and improved coverage among...llment season nears , , B...ly 5 percent of seniors have changed their Medicar...y (16 percent) report they are likely to or are co...
(Date:11/9/2009)...inds that women treated for breast cancer are at h... breasts. Published in the December 15, 2009 issue...can Cancer Society, the study,s results indicate t...benefit from additional therapies following surger...e that women with dense breast tissue are at incre...
(Date:11/8/2009)...HIA, Nov. 8 The America...evention and wellness provisions in the health ref...th passage of this bill, the House takes important...tant insurance reforms and moving our health syste...e that focuses on keeping people healthy," said Ge...
Breaking Medicine News(10 mins):Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 2Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 3Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 4Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 5Health News:Breast density associated with increased risk of cancer recurrence 2Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2
...The U-C-L-A Medical Center, in Los Angeles is witn...on after a heart transplant. His twin, also in nee...// Nick and Nate Draper, the twin brothers wer...enter. According to the Doctors, Nick Draper...
... study led by Ronald Hines, professor of pediatric...ult and children have very different drug metaboli...s (enzymes) in their body for the processing of th...e young. This plays a vital role because certa...
...ior doctor has by the means of BMJ raised a seriou...alization purposes. // This has come after n... approved and thereafter recalled after three mont... Drug Administration in 2004 on the basis of short...
...ses like diabetes, cancer and heart attack that ar...s could cause much strain to the Indian economy, /...ost by 2015, according to estimates by World Healt...s Robert Beaglehole, director of NCD, WHO. H...
...us concerns have been raised regarding the safety ...ports of increased risk of autism // in children ...st mumps, measles and rubella. Currently, ch...nt vaccine preventable diseases. The government ha...
...ed River Valley Water Supply Project's key agenda ...stern North Dakota, especially heavily populated a...ronmental groups are up in arms against this propo...eels that a task of such a magnitude , interbasin ...
Other Medicine News:
(Date:11/9/2009)...CISCO, Calif., Nov. 9 An...on November 5, 2009, it received a letter from The...he Nasdaq Hearing Panel has granted Anesiva,s requ...ket subject to the condition that Anesiva shall ha...roposed merger (the "Merger") contemplated by the ...
(Date:11/7/2009)...la., Nov. 7 Patients reported C1-e...tive therapy in treating acute swelling attacks at...etic disorder, according to data presented today a...p; Immunology (ACAAI) Annual Meeting. The results ...cted in parallel with the ongoing, prospective, op...
(Date:11/6/2009)... WASHINGTON, Pa., Nov. 6 In consul...(FDA), McNeil Consumer Healthcare, Division of McN... a limited number of product lots of TYLENOL®... distinctive red EZ-OPEN CAP. McNeil is initiating...smell or taste associated with these lots that led...
Breaking Medicine Technology:Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 1Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 2Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine 28TM 29 For Prostate Conditions With Start Up of Phase 2 BPH Trial 54732 3Abnormal Protein May Signal Pancreatic Cancer 54730 1Abnormal Protein May Signal Pancreatic Cancer 54730 2Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 1Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 2Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 9609 3
...th Lovenox(R) (enoxaparin sodium injection) were a...l within 90 days-, BRIDGEWATER, N.J., Dec 10 San... that demonstrated total hospital,direct medical c...$550 per,patient when they were treated with the u...actionated heparin (UFH) with 97.3% of LMWH patien...
... 10 Alfacell Corporation,(Nasdaq: ACEL ) today r...r,of fiscal 2008., The company recorded a net los...c and diluted common share, for the fiscal quarter...ion, or $0.05 per basic and diluted,common share, ...administrative expenses increased by approximately...
Other Medicine Technology:Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5Alfacell Reports Financial Results for First Quarter of Fiscal 2008 2Alfacell Reports Financial Results for First Quarter of Fiscal 2008 3Alfacell Reports Financial Results for First Quarter of Fiscal 2008 4Alfacell Reports Financial Results for First Quarter of Fiscal 2008 5
Moody Curved Fixation Forceps
Lindstrom Curved Pierce Forcep
Green Fixation Forceps
Kuhnt Fixation Forceps
Medicine Products: